Clinical trials
Acute Pulmonary Embolism (PE) clinical trials
Below are recruiting acute pulmonary embolism (pe) clinical trials, each written for real people, not researchers. We’re tracking 41 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05098769Recruiting
Prediction tool for risks after acute pulmonary embolism scans
This trial studies a tool that uses CT scan results and heart blood tests to predict the chance of serious outcomes after an acute pulmonary embolism (a blood clot in the lung). It may help doctors identify higher-risk patients sooner.
Shenyang, LiaoningAges 18 years+ - NCT05103670Recruiting
PET/CT lung scan to assess recovery after pulmonary embolism
This study uses a special scan (PET/CT) and an inhaled/linked tracer to measure how well air and blood flow work in different lung areas after a pulmonary embolism. It’s meant to better understand regional lung function and how rehabilitation may help some people recover.
BrestAges 18–99 - NCT05015153Recruiting
Rehab after blood clot in the lungs to improve daily life
This study looks at whether pulmonary rehabilitation (a supervised exercise and support program for lung recovery) improves quality of life after a lung blood clot. It focuses on people who have ongoing breathing-related limits after treatment with blood thinners.
Brest, FranceAges 18 years+ - NCT05050617Recruiting
Ultrasound in the ER to predict risks in pulmonary embolism
This trial checks whether a bedside ultrasound done in the emergency room can help predict which people with an acute pulmonary embolism are more likely to have bad outcomes. If you qualify, your care team will compare ultrasound findings with your later results to see if it can guide treatment decisions sooner.
York, PennsylvaniaAges 18 years+ - NCT04047784Enrolling by invitation
Using EBUS to help diagnose a blood clot in the lungs
This study looks at whether a procedure called EBUS (a camera passed through the airway) can help doctors diagnose an acute pulmonary embolism—a sudden blood clot in the lungs—in critically ill, intubated ICU patients. If you’re eligible, EBUS may be done during bronchoscopy as part of your usual care to help confirm or rule out the diagnosis.
Los Angeles, CaliforniaAges 18 years+ - NCT06695247Recruiting
Walking recovery after serious lung blood clot
This study follows people who had a serious blood clot in their lungs that also affected their heart's right side. It tests how their ability to walk and move changes over 6 months, helping doctors understand recovery better.
Rochester, MinnesotaAges 18–80 - NCT06372730Recruiting
Predicting blood clot return after stopping blood thinners
This study uses a special 3D lung scan (V/Q SPECT/CT) to see if leftover blockages in your lungs can predict if another blood clot will come back. You may be eligible if your doctor has decided it's safe to stop your blood thinners after 3 to 6 months of treatment for a first blood clot.
Amiens, FranceAges 18 years+ - NCT04615130Recruiting
Pulmonary rehab for symptoms after a lung blood clot
This trial studies a structured pulmonary (lung) rehabilitation program for people who still have breathing and activity problems after a pulmonary embolism (PE). It may help improve physical ability and function during recovery.
ViennaAges 18–90 - NCT02156401Recruiting
Study of tests and care to improve clot diagnosis
This study follows adults who may have a blood clot in the lung (pulmonary embolism) or leg (deep vein thrombosis), or who were found to have a clot by chance. It aims to improve how doctors diagnose, manage, and estimate risk, which may lead to better, more tailored care for you.
Mainz, Rhineland-PalatinateAges 18 years+ - NCT07298096Recruiting
Vacuum thrombectomy for pulmonary embolism in cancer patients
This trial tests a computer-assisted vacuum device to remove blood clots from the lungs of people with cancer. It aims to see if this procedure is safe and improves quality of life for those with intermediate-risk pulmonary embolism.
Houston, TexasAges 18 years+ - NCT07270263Recruiting
Lower-dose blood thinners for people with blood cancers
This trial compares lower doses of two common blood thinner pills (apixaban and rivaroxaban) to a daily injection (enoxaparin) to prevent blood clots in people receiving treatment for blood cancers like multiple myeloma, lymphoma, or certain other blood cancers.
Gdansk, Pomeranian VoivodeshipAges 18 years+ - NCT04798261Recruiting
Long-term follow-up after clot removal for pulmonary embolism
This study tracks how patients do long-term after having a clot in the lung treated with a device called the Indigo Aspiration System. It aims to better understand safety and outcomes over time.
Long Beach, CaliforniaAges 18 years+ - NCT06588634Recruiting
A study of a catheter device for high-risk pulmonary embolism
This trial tests a new treatment for people with a severe, high-risk pulmonary embolism (blood clot in the lung). It uses a catheter device to remove the clot and help the heart work better.
New Haven, ConnecticutAges 18 years+ - NCT06051032Recruiting
Comparing balloon vs. suction for clotted dialysis fistulas
This study compares two ways to clear a sudden clot in a dialysis fistula (AVF). It uses either a balloon (to push the clot out) or a suction device (to pull the clot out) to restore blood flow.
Valencia, ValenciaAges 18 years+ - NCT06886516RecruitingEarly Phase 1
Blood thinner study for cancer patients with low platelets
This study tests if the blood thinner apixaban is safe and effective for cancer patients who have low platelets and a recent blood clot. It may offer a treatment option for those who cannot take standard blood thinners.
Boston, MassachusettsAges 18 years+ - NCT06386107Recruiting
Bleeding risk in people with cancer and blood clots on blood thinners
This study looks at how well blood thinners work in people with cancer and a recent blood clot. It measures the risk of bleeding by checking certain blood clotting factors.
Clermont-FerrandAges 18 years+ - NCT06473610Recruiting
Residual blood clots seen on lung scan study
This trial uses a special lung scan (SPECT-CT) to look for leftover blood clots in people with high blood pressure in the lungs or ongoing shortness of breath after a clot. It may help doctors better understand these conditions.
Saint-EtienneAges 18 years+
Hear when a new Acute Pulmonary Embolism (PE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for acute pulmonary embolism (pe)?
- Yes. Clin2 currently lists 41 recruiting acute pulmonary embolism (pe) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a acute pulmonary embolism (pe) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a acute pulmonary embolism (pe) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.